DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
R•• • M••••••
Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Principal held
at least $660,089
sum of BDC pieces, a lower bound
Fair value
$641,936
97c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Feb 4, 2028
$660,089 inside 24 months
On the tape since
Dec 31, 2022
latest Jun 30, 2026
Events
2
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $660,089 | 97c | SOFR+500 bp | Feb 4, 2028 | 1 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• C••••• B•• I••• | term loan first lien Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 5.00% I••••••• R••• 8.73% A••••••••• D• | $356,512 | $346,707 97c | SOFR+500 bp |
| A•••• C••••• B•• I••• | term loan first lien Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 5.00% I••••••• R••• 8.73% A••••••••• D• | $303,577 | $295,229 97c | SOFR+500 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $660,089 | $641,936 | 97c | 0 |
| Mar 31, 2026 | 1 | $665,396 | $647,098 | 97c | 0 |
| Dec 31, 2025 | 1 | $665,396 | $647,098 | 97c | 0 |
| Sep 30, 2025 | 1 | $676,297 | $662,771 | 98c | 0 |
| Jun 30, 2025 | 1 | $687,198 | $679,467 | 99c | 0 |
| Mar 31, 2025 | 1 | $698,099 | $687,627 | 98c | 0 |
| Dec 31, 2024 | 1 | $1.4M | $1.4M | 98c | 0 |
| Sep 30, 2024 | 1 | $698,099 | $675,411 | 97c | 0 |
| Jun 30, 2024 | 1 | $698,099 | $680,647 | 98c | 0 |
| Mar 31, 2024 | 1 | $804,254 | $792,190 | 99c | 0 |
| Dec 31, 2023 | 1 | $1.6M | $1.6M | 98c | 0 |
| Sep 30, 2023 | 1 | $827,795 | $815,379 | 99c | 0 |
| Jun 30, 2023 | 1 | $839,566 | $830,688 | 99c | 0 |
| Dec 31, 2022 | 1 | $863,107 | $856,634 | 100c | 0 |
What changed
- Maturity approachingFeb 4, 2028
- Maturity extended (observed)Mar 31, 2026
- Maturity extended (observed)Mar 31, 2026
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- RMP AND MEDA RXderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it